{
    "id": 20841,
    "fullName": "PAPSS1 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PAPSS1-BRAF results from the fusion of PAPSS1 and BRAF, leads to increased phosphorylation of Mek and Erk, and confers resistance to Raf inhibitors in cell culture (PMID: 24345920), and therefore, is predicted to lead to a gain of function. PAPSS1-BRAF has been identified in melanoma (PMID: 24345920).",
            "references": [
                {
                    "id": 5136,
                    "pubMedId": 24345920,
                    "title": "BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24345920"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 9061,
        "geneSymbol": "PAPSS1",
        "terms": [
            "PAPSS1",
            "ATPSK1",
            "PAPSS",
            "SK1"
        ]
    },
    "variant": "PAPSS1 - BRAF",
    "createDate": "04/08/2016",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 5659,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Mekinist (trametinib) inhibited downstream MAPK signaling in transformed human cells expressing PAPSS1-BRAF in culture (PMID: 24345920).",
            "molecularProfile": {
                "id": 21342,
                "profileName": "PAPSS1 - BRAF"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 5136,
                    "pubMedId": 24345920,
                    "title": "BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24345920"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5657,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Zelboraf (vemurafenib) was incapable of suppressing MAPK signaling in transformed human cells expressing PAPSS1-BRAF in culture (PMID: 24345920).",
            "molecularProfile": {
                "id": 21342,
                "profileName": "PAPSS1 - BRAF"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 5136,
                    "pubMedId": 24345920,
                    "title": "BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24345920"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 21342,
            "profileName": "PAPSS1 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}